Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA-467a-3p is a small, single-stranded, non-coding RNA molecule that functions as a post-transcriptional regulator of gene expression by binding to specific messenger RNAs (mRNAs) and inhibiting their translation or promoting their degradation[7][1]. It has been shown to regulate the **stemness** (self-renewal capacity) and **myogenesis** (muscle cell formation) of satellite cells, which are key for muscle maintenance and regeneration. Dysregulation of miR-467a-3p can contribute to conditions like sarcopenia, an age-associated disease characterized by muscle loss and functional decline. Therapeutic strategies targeting miR-467a-3p, such as antagomiRs and miRNA mimics, are under exploration for influencing satellite cell behavior and for potential use in muscle-degenerative diseases[1][3][5].
AntagomiR-467a-3p: Competitive inhibition of endogenous miR-467a-3p, preventing it from binding its target mRNAs, thereby upregulating target gene expression[1]. miR-467a-3p mimic: Introduction of synthetic miRNA to mimic the function of endogenous miR-467a-3p, increasing suppression of target mRNAs[3][5].
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA-467a-3p (miR-467a-3p).